| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | $46.6M | 19.1M | ▲+8.0% Added · +1.4M sh | Q1 2026 | |
| 2 | TPG GP A, LLC | $45.7M | 18.7M | —Held | Q1 2026 | |
| 3 | STATE STREET CORP | $21.1M | 8.7M | ▲+214% Added · +5.9M sh | Q1 2026 | |
| 4 | PRIMECAP MANAGEMENT CO/CA/ | $20.4M | 8.4M | ▲+2.9% Added · +240K sh | Q1 2026 | |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $16.9M | 6.9M | ▲New +6.9M sh | Q1 2026 | |
| 6 | CITADEL ADVISORS LLC | $16.6M | 6.8M | ▼−44% Reduced · −5.3M sh | Q1 2026 | |
| 7 | PRICE T ROWE ASSOCIATES INC /MD/ | $13.1M | 5.4M | ▲+68% Added · +2.2M sh | Q1 2026 | |
| 8 | TWO SIGMA INVESTMENTS, LP | $13.1M | 5.4M | ▲+57% Added · +2.0M sh | Q1 2026 | |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | $10.1M | 4.1M | ▲+4.9% Added · +191K sh | Q1 2026 | |
| 10 | Frazier Life Sciences Management, L.P. | $9.3M | 3.8M | ▼−1.9% Reduced · −72K sh | Q1 2026 | |
| 11 | Woodline Partners LP | $8.5M | 3.5M | ▲~0% Added · +579 sh | Q1 2026 | |
| 12 | Patient Square Capital LP | $8.4M | 3.5M | ▼−30% Reduced · −1.5M sh | Q1 2026 | |
| 13 | MARSHALL WACE, LLP | $8.4M | 3.4M | ▲12× Added · +3.2M sh | Q1 2026 | |
| 14 | MILLENNIUM MANAGEMENT LLC | $8.1M | 3.3M | ▲+80% Added · +1.5M sh | Q1 2026 | |
| 15 | Candriam S.C.A. | $7.3M | 3.0M | ▲+30% Added · +692K sh | Q1 2026 | |
| 16 | GOLDMAN SACHS GROUP INC | $6.7M | 2.8M | ▲+21% Added · +477K sh | Q1 2026 | |
| 17 | D. E. Shaw & Co., Inc. | $6.7M | 2.8M | ▲+115% Added · +1.5M sh | Q1 2026 | |
| 18 | Boxer Capital Management, LLC | $6.6M | 2.7M | ▲New +2.7M sh | Q1 2026 | |
| 19 | AQR CAPITAL MANAGEMENT LLC | $6.1M | 2.5M | ▲+74% Added · +1.1M sh | Q1 2026 | |
| 20 | Nuveen, LLC | $5.6M | 2.3M | ▲+751% Added · +2.0M sh | Q1 2026 | |
| 21 | MPM BioImpact LLC | $5.5M | 2.2M | ▲New +2.2M sh | Q1 2026 | |
| 22 | RENAISSANCE TECHNOLOGIES LLC | $5.2M | 2.1M | ▼−2.2% Reduced · −48K sh | Q1 2026 | |
| 23 | BANK OF AMERICA CORP /DE/ | $5.2M | 2.1M | ▲+112% Added · +1.1M sh | Q1 2026 | |
| 24 | JACOBS LEVY EQUITY MANAGEMENT, INC | $4.9M | 2.0M | ▲New +2.0M sh | Q1 2026 | |
| 25 | VANGUARD PORTFOLIO MANAGEMENT LLC | $4.1M | 1.7M | ▲New +1.7M sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Company | Co-held by | Combined value |
|---|---|---|
| MICROSOFT CORPMSFT | 65 funds | $26.4B |
| BROADCOM INCAVGO | 65 funds | $15.2B |
| AMAZON.COM INCAMZN | 64 funds | $20.3B |
| META PLATFORMS INC-CLASS AMETA | 64 funds | $11.6B |
| ELI LILLY & COLLY | 64 funds | $6.7B |
| COSTCO WHOLESALE CORPCOST | 64 funds | $5.2B |
| NETFLIX INCNFLX | 64 funds | $4.9B |
| PALANTIR TECHNOLOGIES INC-APLTR | 64 funds | $4.2B |
| APPLE INCAAPL | 63 funds | $30.5B |
| ALPHABET INC-CL AGOOGL | 63 funds | $17.5B |
| TESLA INCTSLA | 63 funds | $7.7B |
| BERKSHIRE HATHAWAY INC-CL BBRK/B | 63 funds | $5.6B |
Ranked by how many of ALLO's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Apr 21, 2026 | Yoshiyama Annie | SVP, Finance | Sell (S) | 10K | $22K |
| Mar 31, 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | Sell (S) | 3K | $7K |
| Mar 16, 2026 | Chang David D | President and CEO, Director | Sell (S) | 48K | $118K |
| Mar 16, 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | Sell (S) | 5K | $12K |
| Mar 2, 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | Sell (S) | 7K | $19K |
| Feb 2, 2026 | Douglas Earl Martin | SVP, General Counsel | Sell (S) | 23K | $40K |
| Feb 2, 2026 | Roberts Zachary | EVP of R&D | Sell (S) | 36K | $63K |
| Feb 2, 2026 | Yoshiyama Annie | SVP, Finance | Sell (S) | 4K | $7K |
| Feb 2, 2026 | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | Sell (S) | 24K | $42K |
| Feb 2, 2026 | Chang David D | President and CEO, Director | Sell (S) | 95K | $171K |
| Feb 2, 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | Sell (S) | 8K | $13K |
| Jan 21, 2026 | Roberts Zachary | EVP of R&D | Sell (S) | 26K | $41K |
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/ALLO/capital-change-brief"
Use Arkolith's capital_change_brief for ALLO. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for ALLO. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.